Certificate of Need Laws: Do Healthcare Mandates Control Costs or Protect Hospital Cartels?

Across state capitals and health policy debates, state Certificate of Need (CON) laws have emerged as a central target for free-market economists, conservative policy institutes, and antitrust enforcement agencies ^{[1], [2], [3]}. First enacted in the late 1960s and early 1970s, CON regulations require healthcare providers to secure explicit approval from a state regulatory board before opening a new hospital, expanding existing bed capacity, building an ambulatory surgery center, or purchasing advanced medical technology such as MRI machines or CT scanners ^{[2], [5]}.

Conservative reform advocates argue that CON laws represent a textbook case of regulatory capture ^{[2], [3]}. Rather than containing medical inflation as originally intended, these laws empower incumbent hospital networks to object during public hearings and effectively veto new, innovative competitors ^{[1], [2]}. Critics contend that this "competitor's veto" artificially restricts the supply of healthcare services, drives up costs, creates long wait times for diagnostic procedures, and worsens healthcare shortages in rural communities ^{[2], [6]}.

A comprehensive examination of data from the Federal Trade Commission (FTC), the U.S. Department of Justice (DOJ), the Kaiser Family Foundation (KFF), and peer-reviewed journals demonstrates that the core conservative critique carries substantial empirical backing, while acknowledging the complex financial mechanisms that keep safety-net hospitals dependent on entry barriers ^{[1], [2], [4], [5]}.

Origins of Health Planning: From 1974 Federal Mandate to State Legacy

To understand the current CON debate, one must examine its historical origins ^{[2], [5]}. In 1974, President Richard Nixon signed the National Health Planning and Resources Development Act, which conditioned federal healthcare funding on states enacting CON programs ^[2]. The prevailing economic theory at the time—often summarized as "Roemer's Law" ("a built bed is a filled bed")—hypothesized that restricting hospital construction would eliminate redundant capacity and curb supply-induced medical spending ^{[2], [3]}.

However, within a decade, empirical evidence revealed that CON laws were failing to constrain medical costs ^{[1], [2]}. Instead of lowering total expenditure, providers diverted capital into non-regulated equipment or inflated service prices to compensate for constrained volume ^{[2], [3]}. Recognizing these unintended consequences, Congress repealed the federal CON mandate in 1986 ^{[2], [5]}.

Following the federal repeal, 15 states dismantled their CON programs entirely, including California, Texas, Pennsylvania, and Arizona ^{[2], [5]}. Yet, 35 states and the District of Columbia continue to enforce varying degrees of CON regulation in 2026, covering hospital expansions, nursing homes, psychiatric facilities, ambulatory surgical centers, and heavy diagnostic machinery ^{[2], [5]}.

What the Data Shows: Supply Restrictions, Price Inflation, and Access Barriers

Decades of econometric research from health economists, academic institutions, and federal antitrust agencies yield consistent findings regarding the real-world effects of CON laws ^{[1], [2], [3]}:

1. Substantial Reductions in Medical Supply and Bed Capacity

Studies published by the Mercatus Center at George Mason University, led by economists Dr. Matthew Mitchell and Dr. Thomas Stratmann, demonstrate that CON laws significantly suppress the supply of healthcare facilities ^{[2], [3]}. Controlling for state demographic and economic variables, states with CON programs have on average 131 fewer hospital beds per 100,000 residents than non-CON states ^[2]. In times of sudden demand spikes—such as seasonal respiratory surges or public health emergencies—this suppressed capacity leads to higher hospital occupancy rates and severe bed shortages ^{[2], [3]}.

2. Higher Per-Unit Costs and Price Inflation

Joint policy statements and research reports by the Federal Trade Commission (FTC) and the Department of Justice (DOJ) Antitrust Division have repeatedly concluded that CON laws act as a barrier to market entry that shields incumbents from competition ^[1]. By insulating existing hospitals from low-cost, independent competitors—such as ambulatory surgical centers or physician-owned diagnostic clinics—CON laws diminish competitive pressure to lower prices or improve service quality ^{[1], [2]}. Statistical analyses in the Southern Economic Journal show that per-capita healthcare spending in states with comprehensive CON programs is 3% to 5% higher than in states without CON regulations ^[3].

3. Diagnostic Imaging Bottlenecks and Access Disparities

CON regulations frequently apply to high-tech diagnostic equipment, requiring providers to prove "community need" before purchasing MRI or CT scanners ^{[2], [5]}. Research shows that CON states have 42% fewer MRI scanners and 26% fewer CT scanners per capita than non-CON states ^[2]. This artificial scarcity increases wait times for diagnostic procedures and drives diagnostic imaging into high-cost hospital outpatient departments rather than lower-cost independent imaging centers ^{[1], [2]}.

The Full Picture: Safety-Net Cross-Subsidization and Incumbent Arguments

While economic evidence strongly highlights the anti-competitive drawbacks of CON laws, a fair analysis must evaluate why hospital associations and safety-net advocates continue to defend them ^[4]. The American Hospital Association (AHA) and regional hospital groups emphasize that healthcare markets do not operate like traditional free markets due to federal EMTALA mandates, fixed public insurance reimbursement rates (Medicare/Medicaid), and high rates of uncompensated indigent care ^[4].

The primary defense of CON laws rests on three structural arguments ^[4]:

• Preventing "Cherry-Picking" by Niche Competitors: Full-service, non-profit hospitals rely on lucrative elective procedures (e.g., orthopedic surgeries, outpatient imaging) to cross-subsidize essential but unprofitable operations, such as 24/7 emergency departments, level-1 trauma centers, burn units, and psychiatric wards ^[4]. Proponents argue that without CON restrictions, investor-owned specialty centers will "cherry-pick" commercially insured patients, leaving safety-net hospitals with a high proportion of Medicaid and uninsured patients ^[4].
• Financial Stability of Rural and Urban Safety-Net Facilities: Hospital networks assert that unregulated entry of new surgical centers in affluent suburbs drains vital revenue from regional medical centers, potentially threatening the financial solvency of safety-net institutions ^[4].
• Avoiding Costly Capital Over-Investment: Proponents maintain that unrestricted competition leads to redundant, underutilized high-cost facilities, driving up overall system overhead that is ultimately passed along to health insurers and taxpayers ^[4].

However, empirical research challenges whether CON laws actually protect safety-net hospitals ^{[2], [6]}. Studies comparing safety-net hospital margins in CON vs. non-CON states find no statistically significant difference in the amount of charity care provided or overall financial health ^{[2], [6]}. Furthermore, research shows that CON states actually have 30% fewer rural hospitals per capita, suggesting that CON boards often serve to protect established suburban health systems rather than fragile rural providers ^{[2], [6]}.

Lessons from Recent State Repeals: Florida, South Carolina, and North Carolina

Recent state legislative reforms offer real-world evidence on the impact of CON deregulation ^{[2], [5]}. In 2019, Florida enacted landmark legislation (HB 21) repealing CON requirements for general acute care hospitals, complex medical tertiary care, and pediatric open-heart surgery ^[5]. In the years following repeal, Florida experienced an influx of new ambulatory surgical centers and hospital bed expansions, expanding patient choice and increasing competition without reducing community safety-net care ^{[2], [5]}.

Similarly, South Carolina passed Act 36 in 2023, systematically repealing CON oversight for most hospital facilities and medical equipment ^[5]. Early evaluations indicate accelerated capital investment in ambulatory care centers and reduced legal expenditures previously spent fighting CON appeals ^{[2], [5]}. In North Carolina, 2023 legislation (HB 259) raised CON exemption thresholds for ambulatory surgical centers and diagnostic equipment in exchange for Medicaid expansion, signaling a growing bipartisan willingness to dismantle regulatory entry barriers ^[5].

Conclusion: Neutral Synthesis and the Path Forward

The conservative and free-market critique of Certificate of Need laws is strongly supported by empirical economics and antitrust law ^{[1], [2], [3]}. Conceived as a cost-control mechanism in the 1970s, CON laws have instead functioned as state-sanctioned entry barriers that restrict medical capacity, reduce diagnostic availability, and insulate incumbent healthcare monopolies from price competition ^{[1], [2]}.

At the same time, policy experts emphasize that repealing CON laws is not a standalone silver bullet for healthcare inflation ^{[4], [5]}. Because hospital financing relies heavily on cross-subsidies between profitable elective services and loss-leading emergency care, state lawmakers transitioning away from CON programs must pair deregulation with transparent reimbursement policies and targeted support for safety-net facilities ^{[4], [5]}. Replacing bureaucratic entry barriers with genuine market competition offers the most promising path toward expanding access, lowering prices, and building a more resilient American healthcare system ^{[1], [2]}.